UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers

PloS one, 2017-03, Vol.12 (3), p.e0174413-e0174413

2017

Volltextzugriff (PDF)

Miz‐1 and Max compete to engage c‐Myc: implication for the mechanism of inhibition of c‐Myc transcriptional activity by Miz‐1

Proteins, structure, function, and bioinformatics, 2017-02, Vol.85 (2), p.199-206

2017

Volltextzugriff (PDF)

NMR structure note: solution structure of human Miz-1 zinc fingers 8 to 10

Journal of biomolecular NMR, 2012-11, Vol.54 (3), p.317-323

2012

Volltextzugriff (PDF)

Miz-1 and Max compete to engage c-Myc: implication for the mechanism of inhibition of c-Myc transcriptional activity by Miz-1: Miz-1 and Max Compete to Engage c-Myc

Proteins, structure, function, and bioinformatics, 2017-02, Vol.85 (2), p.199-206

2017

Volltextzugriff (PDF)

Biophysical characterization of the b-HLH-LZ of [DELTA]Max, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers

PloS one, 2017-03, Vol.12 (3), p.e0174413

2017

Volltextzugriff (PDF)

Abstract A11: Biophysical characterization of the b-HLH-LZ of deltaMax

Molecular cancer research, 2015-10, Vol.13 (10_Supplement), p.A11-A11

2015

Volltextzugriff (PDF)

Abstract B23: Pushing Myc inhibition towards the clinic by direct delivery of cell-penetrating peptides

Molecular cancer research, 2015-10, Vol.13 (10_Supplement), p.B23-B23

2015

Volltextzugriff (PDF)

High‐frequency longitudinal white matter diffusion‐ and myelin‐based MRI database: Reliability and variability

Human brain mapping, 2023-06, Vol.44 (9), p.3758-3780

2023

Volltextzugriff (PDF)

Abstract 3956: Omomyc-based cell-penetrating peptides: From proof of concept to a clinically viable anti-Myc therapy

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3956-3956

2018

Volltextzugriff (PDF)

Abstract 2167: Preclinical validation of an Omomyc cell-penetrating peptide as a viable anti-Myc therapy

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2167-2167

2017

Volltextzugriff (PDF)

Abstract PR10: Preclinical validation of Myc inhibition by a new generation of Omomyc-based cell penetrating peptides

Molecular cancer research, 2015-10, Vol.13 (10_Supplement), p.PR10-PR10

2015

Volltextzugriff (PDF)

1 – 12 von 12

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieNeuroimage Clinical

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(12)

Sprache

Englisch
(12)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Molecular Cancer Research
(3)
Cancer Research
(2)
Plos One
(2)
Proteins, Structure, Function, And Bioinformatics
(2)
Human Brain Mapping
(1)
Journal Of Biomolecular Nmr
(1)
Science Translational Medicine
(1)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers

Miz‐1 and Max compete to engage c‐Myc: implication for the mechanism of inhibition of c‐Myc transcriptional activity by Miz‐1

Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy

NMR structure note: solution structure of human Miz-1 zinc fingers 8 to 10

Miz-1 and Max compete to engage c-Myc: implication for the mechanism of inhibition of c-Myc transcriptional activity by Miz-1: Miz-1 and Max Compete to Engage c-Myc

Biophysical characterization of the b-HLH-LZ of [DELTA]Max, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers

Abstract A11: Biophysical characterization of the b-HLH-LZ of deltaMax

Abstract B23: Pushing Myc inhibition towards the clinic by direct delivery of cell-penetrating peptides

High‐frequency longitudinal white matter diffusion‐ and myelin‐based MRI database: Reliability and variability

Abstract 3956: Omomyc-based cell-penetrating peptides: From proof of concept to a clinically viable anti-Myc therapy

Abstract 2167: Preclinical validation of an Omomyc cell-penetrating peptide as a viable anti-Myc therapy

Abstract PR10: Preclinical validation of Myc inhibition by a new generation of Omomyc-based cell penetrating peptides

Aktive Filter

Suchergebnisse filtern